|
Atomistry » Fluorine » PDB 5hu1-5iev » 5ia4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Fluorine » PDB 5hu1-5iev » 5ia4 » |
Fluorine in PDB 5ia4: Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Foretinib (XL880)Enzymatic activity of Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Foretinib (XL880)
All present enzymatic activity of Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Foretinib (XL880):
2.7.10.1; Protein crystallography data
The structure of Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Foretinib (XL880), PDB code: 5ia4
was solved by
D.Kudlinzki,
V.L.Linhard,
S.L.Gande,
S.Sreeramulu,
K.Saxena,
S.Heinzlmeir,
G.Medard,
B.Kuester,
H.Schwalbe,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Foretinib (XL880)
(pdb code 5ia4). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Foretinib (XL880), PDB code: 5ia4: Jump to Fluorine binding site number: 1; 2; Fluorine binding site 1 out of 2 in 5ia4Go back to Fluorine Binding Sites List in 5ia4
Fluorine binding site 1 out
of 2 in the Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Foretinib (XL880)
Mono view Stereo pair view
Fluorine binding site 2 out of 2 in 5ia4Go back to Fluorine Binding Sites List in 5ia4
Fluorine binding site 2 out
of 2 in the Crystal Structure of Ephrin A2 (EPHA2) Receptor Protein Kinase with Foretinib (XL880)
Mono view Stereo pair view
Reference:
S.Heinzlmeir,
D.Kudlinzki,
S.Sreeramulu,
S.Klaeger,
S.L.Gande,
V.Linhard,
M.Wilhelm,
H.Qiao,
D.Helm,
B.Ruprecht,
K.Saxena,
G.Medard,
H.Schwalbe,
B.Kuster.
Chemical Proteomics and Structural Biology Define EPHA2 Inhibition By Clinical Kinase Drugs. Acs Chem. Biol. V. 11 3400 2016.
Page generated: Thu Aug 1 10:09:46 2024
ISSN: ESSN 1554-8937 PubMed: 27768280 DOI: 10.1021/ACSCHEMBIO.6B00709 |
Last articlesZn in 9JPJZn in 9JP7 Zn in 9JPK Zn in 9JPL Zn in 9GN6 Zn in 9GN7 Zn in 9GKU Zn in 9GKW Zn in 9GKX Zn in 9GL0 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |